RLYB116
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for RLYB116, covering 2026-02-27 to 2026-02-27. Get the full timeline:
Most recent: Clinical Trial Update: Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of RLYB116 in Healthy Participants [Phase 1]